Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
News Medical: Mutation profiles and clinicopathological correlations in lung squamous cell carcinoma
Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...
ascopubs.org: Exploring the evolving therapeutic landscape of stage IV lung squamous cell carcinoma: A 13-year single center experience.
Exploring the evolving therapeutic landscape of stage IV lung squamous cell carcinoma: A 13-year single center experience.
ascopubs.org: Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis.
Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis.
Image of a lung lobe from a carcinogen-exposed mouse. Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of ...
EurekAlert!: Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma
Relationship between mutation profile detected by next-generation sequencing and histopathological parameters in lung squamous cell carcinoma
Squamous cell lung cancer starts in the squamous cells: thin, flat cells that line the inside of the airways in your lungs. If you're diagnosed after the cancer has spread, it tends to be more ...
ascopubs.org: Safety and Efficacy of Antiangiogenesis Agents in Patients With Squamous Cell Carcinoma of the Lung: Time to Revise Outdated Constraints